UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): | May 19, 2009 |
CONVERTED ORGANICS INC.
__________________________________________
(Exact name of registrant as specified in its charter)
Delaware | 001-33304 | 204075963 |
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
of incorporation) | File Number) | Identification No.) |
7A COMMERCIAL WHARF WEST, BOSTON, Massachusetts | 02110 | |
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
Registrants telephone number, including area code: | 617-624-0111 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On May 19, 2009, Converted Organics Inc. ("we" or "our") entered into a Securities Purchase Agreement with four institutional investors. Pursuant to the Securities Purchase Agreement, we agreed to issue to these investors in the aggregate: (a) 1,500,000 shares of our common stock; and (b) warrants to purchase an additional 1,500,000 shares of our common stock at an exercise price of $1.40 per share ("Warrants"). The Warrants may be exercised at any time on or after their date of issuance and for a three-month period thereafter. We expect the offering close on or about May 20, 2009.
Chardan Capital Markets, LLC, as placement agent, acted on a best efforts basis for the offering and will receive a placement fee equal to $147,000.
We are making the offering and sale of the above shares and Warrants pursuant to a shelf registration statement on Form S-3 (Registration No. 333-158784) declared effective by the Securities and Exchange Commission on May 19, 2009, and a base prospectus dated as of the same date, as supplemented by a prospectus supplement to be filed with the Securities and Exchange Commission on May 20, 2009.
The descriptions of terms and conditions of the Securities Purchase Agreement and Warrants set forth herein do not purport to be complete and are qualified in their entirety by the full text of the form of Securities Purchase Agreement, which is attached hereto as Exhibit 10.1 and incorporated herein by reference and the form of the Warrants, which is attached hereto as Exhibit 4.1 and incorporated by reference herein.
A copy of the press release making the announcement of the offering is filed herewith as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
Exhibits:
4.1 Form of Warrant
10.1 Form of Securities Purchase Agreement dated May 19, 2009
99.1 Press Release dated May 20, 2009.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CONVERTED ORGANICS INC. | ||||
May 20, 2009 | By: |
/s/ Edward J. Gildea
|
||
|
||||
Name: Edward J. Gildea | ||||
Title: President and CEO |
Exhibit Index
Exhibit No. | Description | |
|
|
|
4.1
|
Form of Warrant | |
10.1
|
Form of Securities Purchase Agreement dated May 19, 2009 | |
99.1
|
Press Release dated May 20, 2009 |